The goals of Project 3 are two-fold. The first goal is to develop in vitrolex vivo models of acute intoxication by seizurogenic chemical threat agents by applying high content, rapid throughput technology to quantitatively detect disruption of electrical and Ca^* signaling events that are known to contribute to seizure induction, severity, and promote neuronal damage. The second goal is to apply these methods to investigate existing and new therapeutic strategies for mitigating onset, progression, and severity of seizures elicited by acute intoxication with the GABA antagonist tetramethylenedisulfotetramine (TETS) and the organophosphorus (OP) cholinesterase inhibitor diisopropylfluorophosphate (DFP). The Axion multi-well multichannel electrode arrays permit unparalleled sensitivity in detecting patterns of electrical burst-spike activity in both dissociated neurons and brain slices, whereas the 96-well Tetra High Throughput Cellular Screening System (FLIPR) provides real-time assessments of spontaneous and evoked Ca oscillations. Relevant in vitro systems, including cultures enriched for primary neurons, mixed astrocyte-neuronal co-cultures, and hippocampal slices are chosen for model development because of their predictive value to Projects 1 and 2. A major outcome of the proposed studies will be to screen existing therapeutic leads and discover new therapeutic targets (with Cores A and B) that delay or mitigate triggered seizure activity and subsequent neuropathology produced by TETS and DFP. These in vitro approaches will identify the most promising therapeutic candidates and drug combinations for in vivo testing in Projects 1 and 2. Further validation and optimization of therapeutic strategies, including timing of administration, dosages, and drug combinations, will be assessed ex vivo in a reiterative process with Projects 1 and 2. The receptor based rapid-throughput approaches proposed in Project 3 will expedite more efficient formulation of optimal therapeutic strategies by Cores A and B. Moreover, the molecular and cellular mechanisms by which TETS and DFP alter the fidelity of Ca2+ signaling events to promote injurious neuronal excitability will improve our understanding of how these threat agents promote seizures and impair neural networks, providing insight into novel drug targets. Additional major milestones of the in vitro/ex vivo approach proposed in Project 3 are to accelerate: (1) Implementation of existing therapeutic agents approved for use in humans or currently undergoing clinical trials (referred to in this proposal as Tier 1), and (2) identify new receptor-targeted compounds and mixtures that improve our ability to treat acute (convulsant) and delayed (neuropathology) harm caused by exposures to seizurogenic threat agents (referred to as Tier 2 candidates).
Aim 1 : Develop rapid throughput multielectrode array (MEA) and high-resolution imaging methods to efficiently detect and discriminate threat agents that trigger electrical burst-spike activity, those that dysregulate neuronal Ca2+ signaling, and those that have both activities. 1 .a. Investigate if TETS produces electrical burst-spike activity and abnormal Ca2+ oscillations in neuronal cell cultures and/or neuron/glia co-cultures. I.b. Determine whether TETS and DFP produce similar patterns of burst-spike (epileptiform) activity in acutely dissociated hippocampal slices.
Aim 2 : Determine whether Tier 1 and novel Tier 2 therapeutic candidates, singly or in combination, ameliorate electrical and Ca2+ signaling disturbances triggered by TETS and/or DFP.
Aim 3 : Investigate if therapeutic candidates that target Ca2+ -dependent signaling events provide added neuroprotection against TETS- and DFP-triggered chronic neuropathology. 3.a. Determine whether exposures to TETS or DFP, in the presence or absence of therapeutic intervention, in vivo persistently alters the electrophysiological and Ca2+ signaling properties of hippocampal neurons and slices prepared ex vivo. 3.b. Determine whether exposures to TETS or DFP, in the presence or absence of therapeutic intervention, in vivo persistently alters the biomarkers of oxidative stress and chronic neuropathology in hippocampal neurons and slices prepared ex vivo.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54NS079202-03
Application #
8730733
Study Section
Special Emphasis Panel (ZRG1-MDCN-J)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
3
Fiscal Year
2014
Total Cost
$434,651
Indirect Cost
$148,565
Name
University of California Davis
Department
Type
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Wagner, K; Lee, K S S; Yang, J et al. (2016) Epoxy fatty acids mediate analgesia in murine diabetic neuropathy. Eur J Pain :
Cao, Zhengyu; Xu, Jian; Hulsizer, Susan et al. (2016) Influence of tetramethylenedisulfotetramine on synchronous calcium oscillations at distinct developmental stages of hippocampal neuronal cultures. Neurotoxicology 58:11-22
Sharma, Amit; Hye Khan, Md Abdul; Levick, Scott P et al. (2016) Novel Omega-3 Fatty Acid Epoxygenase Metabolite Reduces Kidney Fibrosis. Int J Mol Sci 17:
Tong, Xiaoyong; Khandelwal, Alok R; Wu, Xiaojuan et al. (2016) Pro-atherogenic role of smooth muscle Nox4-based NADPH oxidase. J Mol Cell Cardiol 92:30-40
Bever, Candace S; Dong, Jie-Xian; Vasylieva, Natalia et al. (2016) VHH antibodies: emerging reagents for the analysis of environmental chemicals. Anal Bioanal Chem 408:5985-6002
Chapman, Christopher A R; Chen, Hao; Stamou, Marianna et al. (2016) Mechanisms of Reduced Astrocyte Surface Coverage in Cortical Neuron-Glia Co-cultures on Nanoporous Gold Surfaces. Cell Mol Bioeng 9:433-442
Zhou, Yong; Liu, Tian; Duan, Jia-Xi et al. (2016) Soluble Epoxide Hydrolase Inhibitor Attenuates Lipopolysaccharide-Induced Acute Lung Injury and Improves Survival in Mice. Shock :
Flannery, Brenna M; Bruun, Donald A; Rowland, Douglas J et al. (2016) Persistent neuroinflammation and cognitive impairment in a rat model of acute diisopropylfluorophosphate intoxication. J Neuroinflammation 13:267
Pessah, Isaac N; Rogawski, Michael A; Tancredi, Daniel J et al. (2016) Models to identify treatments for the acute and persistent effects of seizure-inducing chemical threat agents. Ann N Y Acad Sci 1378:124-136
Gao, Jie; Naughton, Sean X; Wulff, Heike et al. (2016) Diisopropylfluorophosphate Impairs the Transport of Membrane-Bound Organelles in Rat Cortical Axons. J Pharmacol Exp Ther 356:645-55

Showing the most recent 10 out of 58 publications